Paloma Partners Management Co - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
Paloma Partners Management Co ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$30,465,000
+236.2%
358,288
+40.1%
0.77%
+391.1%
Q2 2020$9,062,000
+2027.2%
255,701
+1170.3%
0.16%
+2516.7%
Q4 2019$426,000
-54.1%
20,129
-86.0%
0.01%
-45.5%
Q1 2017$929,000
+153.1%
143,653
+43.7%
0.01%
+175.0%
Q4 2016$367,000
+395.9%
100,000
+211.7%
0.00%
+300.0%
Q2 2016$74,000
+7.2%
32,086
+73.5%
0.00%
-66.7%
Q3 2014$69,00018,4950.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders